Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
Haroun Gajraj, Phlebologist and Board Member of the British Association of Sclerotherapists, shared a post on LinkedIn about a recent article by Gabriel Henrique Simoni et al., published in JVS-VL, adding:
“Cryo-Laser and Cryo- Sclerotherapy
Why is your patient asking about CLaCS before you’ve had the chance to explain it?
A patient walks into your clinic having already watched a video of CLaCS: the vein map projected onto the skin, the laser, the cold air, the injection.
She’s read that it clears leg veins with less bruising and less staining than sclerotherapy. And she wants to know why you are not offering it.
In this clip from my new video, I set up the question I spend the rest of it answering…
What does the first-ever pooled meta-analysis of CLaCS against sclerotherapy alone actually show, and what does it leave out?
The headline figures tell one story.
What the comparison group in the largest trial actually received tells a very different one.
Full breakdown, including the evidence tables and the guideline positions, goes live Wednesday.
Link to the full article and video in the comments on Wednesday 12th August.”
Title: Cryo-Laser Cryo-Sclerotherapy Versus Isolated Sclerotherapy for Telangiectasias and Reticular Veins a Systematic Review and Meta-Analysis
Authors: Gabriel Henrique Simoni, Dario Madera, Nikolaos Papatheodorou, Samantha Neves, Ana Clara Pizarro Varella, Julia Gonçalves Alonso, Nasser Mahfouz
Proceed to the video attached to the post.
Other posts featuring Haroun Gajraj on Hemostasis Today.
-
Aug 11, 2026, 05:38Rami Unterman: A Simple New Biomarker for Fibrotic ILDs
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria
-
Aug 10, 2026, 16:51Suebsarn Ruksakulpiwat։ A New Milestone in the Development of the Stroke Risk Screening Scales
-
Aug 10, 2026, 16:09Preetie Shetty Akkunje: Making Stroke Rehabilitation Accessible in Low-Resource Settings
-
Aug 10, 2026, 15:50The Next Antithrombotic Frontier: GPVI Inhibitors Beyond Aspirin